Related Experiment Video
Updated: May 13, 2026

09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression
Jackson J Cone1, Elena H Chartoff, David N Potter
1Graduate Program in Neuroscience, University of Illinois at Chicago, Chicago, Illinois, USA.
Plos One
|March 22, 2013
Summary
High-fat diets alter dopamine transporter function and dopamine reuptake after six weeks, independent of obesity development. These diet-induced changes in dopamine signaling occur without affecting total dopamine transporter protein levels.
Area of Science:
- Neuroscience
- Dietary Science
- Molecular Biology
Background:
- Diet-induced obesity (DIO) impacts dopamine signaling, including dopamine transporter (DAT) expression and dopamine reuptake.
- The precise timeline of diet-induced DAT alterations and their dependence on DIO remain unclear.
Purpose of the Study:
- To investigate the time-course of diet-induced changes in DAT function and expression.
- To determine if these changes are linked to the development of DIO.
Main Methods:
- Rats were fed high-fat (HFD) or low-fat (LFD) diets for 2 or 6 weeks.
- Striatal DAT function was assessed using fast-scan cyclic voltammetry.
- Membrane-associated DAT levels were quantified via Western blot.
Main Results:
- A deficit in dopamine reuptake was observed in HFD rats after 6 weeks, but not 2 weeks.
- Cocaine-induced dopamine release was attenuated in HFD rats.
- Total DAT protein remained unchanged, but a 50 kDa DAT isoform was reduced in synaptosomal membranes after 6 weeks of HFD.
Conclusions:
- Diet-induced alterations in dopamine reuptake can occur without changes in total DAT production.
- These dopamine signaling changes manifest even without the development of diet-induced obesity.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

